Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...

ProKidney’s Rilparencel shows promise for CKD patients, with Phase 2 data expected in 2025. Learn why PROK stock is a “Buy” ...

Nightingale Health Plc Press release 7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulato ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

The Small Molecule Drug Discovery Market size is expected to be worth around USD 121.8 billion by 2033 from USD 52.5 billion in 2023, growing at a CAGR of 8.8% ...

Quarterly season is nearing its end, triggering a rush from small caps to hit the month-end reporting deadline.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...